Paperpal Prime Logo

Gynecologic Oncology : Impact Factor & More

eISSN: 1095-6859pISSN: 0090-8258

Aims and Scope of Gynecologic Oncology

Gynecologic Oncology is a peer-reviewed medical journal covering all aspects of gynecologic oncology. The journal covers investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest. It is published by Elsevier and is the official journal of the Society of Gynecologic Oncology. Less

Key Metrics

CiteScore
7.4
Eigenfactor
0.01 - 0.05
H-Index
180
Impact Factor
< 5
Scite Index
0.86 5-Year SI
SJR
Q1Oncology
SNIP
1.54
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Gynecologic Oncology

Gynecologic Oncology Journal Specifications

Overview
Publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1972
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Gynecologic Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Gynecologic Oncology

Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.
  • 8 Aug 2026
  • Journal of the National Cancer Institute
Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.
  • 8 Aug 2026
  • Gynecologic oncology
Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes.
  • 7 Aug 2026
  • Gynecologic oncology
Factors associated with non-completion of gynecological cancer clinical trials.
  • 7 Aug 2026
  • Gynecologic oncology
Feasibility, adherence, and patient experiences in a pilot randomized trial of home-based cognitive training intervention for gynecologic cancer-related cognitive impairment.
  • 7 Aug 2026
  • Gynecologic oncology
Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.
  • 6 Aug 2026
  • Gynecologic oncology
Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.
  • 8 Aug 2026
  • Journal of the National Cancer Institute
Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.
  • 8 Aug 2026
  • Gynecologic oncology
Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes.
  • 7 Aug 2026
  • Gynecologic oncology
Factors associated with non-completion of gynecological cancer clinical trials.
  • 7 Aug 2026
  • Gynecologic oncology
Feasibility, adherence, and patient experiences in a pilot randomized trial of home-based cognitive training intervention for gynecologic cancer-related cognitive impairment.
  • 7 Aug 2026
  • Gynecologic oncology
Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.
  • 6 Aug 2026
  • Gynecologic oncology

FAQs on Gynecologic Oncology